Bangladesh's first corporate restructuring rules: what should change before gazette

The consultation window

On 23 May 2026, the Commission opened public consultation on the draft BSEC (Corporate Restructuring) Rules, 2026. The window closed on 7 June 2026. If gazetted, Bangladesh will have its first dedicated framework for listed-company restructuring. Until now, these transactions have mainly relied on the Companies Act, 1994 and case-by-case regulatory oversight. That is a meaningful shift. The real test is whether the final version gives investors clear process, clear valuation discipline and clear remedies when they disagree with a scheme.

Draft rule highlights

For listed companies, restructuring has long sat between company law, Court judgement and regulatory discretion. The draft rules create a dedicated process around the shareholders most exposed to these transactions: public investors who do not negotiate the scheme but live with its consequences.

The draft introduces a three-stage approval route through the Commission, the Stock Exchange (DSE/CSE), and the Court. It also requires independent valuation, a fairness opinion, audit-committee review, detailed disclosure schedules and a prohibition on backdoor listings. For M&A advisers, corporate finance teams and boards in Bangladesh, this changes how amalgamation, merger, demerger and acquisition schemes should be planned. Regulatory review would come before the Court stage, while the Court remains the forum that sanctions the scheme under company law.

The most important change is the discipline placed on non-listed companies entering a listed structure. A transferor company can no longer arrive inside a listed company without listed-company levels of disclosure, valuation support and regulatory review. As restructuring fixes exchange ratios, moves assets and changes shareholder economics in one transaction, public shareholders need more than a vote; they need information that can be assessed.

What is covered, what is still open

The draft deserves credit for putting listed-company restructuring on a formal track. It brings valuation, fairness review, disclosure and regulator scrutiny into one process. The open points are narrower, but they are not cosmetic. They sit around minority exit, voting mechanics and deal certainty, which are the areas where a protection either works or does not.

The right-hand column is not a reason to reject the framework. It is the drafting agenda before gazette. Most of it can be fixed with targeted provisions rather than a redesign.

Bangladesh market context

The weakest part of any restructuring rule is the assumption that minority investors can protect themselves through the market. In Bangladesh, that assumption needs caution. The market is shallow, foreign participation is thin, and many listed companies still have concentrated sponsor ownership. If a minority holder dislikes a scheme, selling in the market may not produce a fair-value exit. If a scheme goes to vote, dispersed retail holders may not have the coordination or information advantage that institutions usually provide.

This is the direct link to the draft rule. A dissenter exit is not a theoretical concept; it is the remedy that matters when market liquidity is thin. A minority approval test is not just a percentage; it is a turnout design problem in a retail-heavy market. Excluding every holder above 5% may remove the investors most able to examine the scheme, including institutions such as ICB, mutual funds and insurance companies. Without a quorum and without institutional participation, the threshold can become either too hard to achieve or too easy for a small organised group to control.

The takeover-rule overlap matters for the same reason. A restructuring that shifts control should not become a route around open-offer protections under the BSEC (Substantial Acquisition of Shares, Takeover and Control) Rules, 2018. In a market where retail investors are numerous but not always coordinated, the final rules need to make the route, remedy and voting base explicit.

Where minority protection can break

The transaction path is not the same as the investor-protection path. The draft creates strong review points around BSEC, Exchanges, valuation and disclosure. The remaining risk sits where an investor disagrees with the deal, where the review timeline slips, or where a tiny residual minority remains after approval.

Four gaps to close

Four points carry the most practical weight. Each one relates to a protection that is assumed by the framework but not fully provided in the drafting.

Discount-rate drafting point

One technical point is smaller but important. Schedule B sets the discount rate for valuation at "not less than" the 10-year Treasury bond yield. The likely intention is to stop artificially low rates that inflate value. In a standard equity valuation, however, the cost of equity should already exceed the risk-free rate. The better drafting approach is to anchor the rate to accepted methodology, such as CAPM or WACC, with the Treasury yield as the risk-free input rather than the discount rate itself.

A similar drafting point applies to revenue growth assumptions. If the final rules allow a tolerance above historical CAGR, the text should say clearly whether the tolerance is measured in percentage points or as a relative percentage variance. That small wording choice matters in valuation, especially for companies coming off a low-growth base.

Recommendations in the ClairVise submission

The full regulatory submission works through the draft clause by clause. Each recommendation identifies the issue, proposes drafting and compares the point with relevant regimes, including India's SEBI takeover regulations, the UK Takeover Code and Listing Rules, the UK Companies Act 2006, section 230 of the Indian Companies Act, 2013, and the International Valuation Standards (IVS) 2025. The matrix below is the condensed version.

Practical takeaway

Issuers and advisers should treat the three-stage pathway, independent valuation and fairness opinion as the new floor for listed-company schemes. Deal timelines also need to account for regulator review before Court judgement. Minority investors gain more disclosure than they had before, but until an exit mechanism exists, a shareholder who opposes a scheme still has no fair-value route out of it.

The final framework would be stronger with six targeted additions: a dissenter exit at fair value, workable public-shareholder voting mechanics, a defined consequence for review delay, a squeeze-out route for residual holders, clearer valuation provisions and explicit coordination with the 2018 takeover regime and the tax code. The draft is close enough to be taken seriously. With the consultation now closed, these protections should be settled before gazette.

References

• Bangladesh Securities and Exchange Commission: draft BSEC (Corporate Restructuring) Rules, 2026; public-consultation notice, 23 May 2026. sec.gov.bd
• BSEC (Substantial Acquisition of Shares, Takeover and Control) Rules, 2018. sec.gov.bd
• Companies Act, 1994 (Bangladesh): schemes of arrangement and amalgamation. Bangladesh Statute
• The Business Standard: BSEC review to become mandatory before Court approval in corporate restructuring, 23 May 2026. tbsnews.net
• The Financial Express: CDBL/DSE market capitalisation, total BO accounts and zero-share BO accounts, 25 March 2026. thefinancialexpress.com.bd
• The Business Standard: DSE budget reform proposals citing foreign participation below 2%, 2026. tbsnews.net
• International Valuation Standards (IVS) 2025. ivsc.org
• Comparable regimes referenced in the submission: SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (India); UK Takeover Code; UK Listing Rules; UK Companies Act 2006 (ss. 895–899, 979–982); section 230 of the Indian Companies Act, 2013. Primary Regulators' official sites